Clinical Trials Browser

Phase 1 × Advanced Cancer × Clear all

NCT07269145 2026-01-28

A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TQB3122 Capsules in Subjects With Advanced Malignant Tumors

Phase 1 Recruiting

Advanced Cancer

NCT01087554 2026-01-16

Sirolimus or Everolimus or Temsirolimus and Vorinostat in Advanced Cancer

Phase 1 Active not recruiting

Advanced Cancer

NCT07291050 2025-12-18

A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TQB3217 Tablets in Subjects With Advanced Malignant Tumors

Phase 1 Not yet recruiting

Advanced Cancer

NCT06662760 2025-11-25

Clinical Trial of TQB3002 in Patients With Advanced Cancers

Phase 1 Recruiting

Advanced Cancer

NCT05025085 2025-10-15

A Study Investigating AGEN1777 in Participants With Advanced Solid Tumors

Phase 1 Completed

Advanced Cancer

NCT03900442 2025-09-02

Phase 1 Study of PTX-100 in Patients With Advanced Malignancies With PTCL Expansion Cohort

Phase 1 Completed

Advanced Cancer

NCT06092580 2025-09-02

Phase 1 Study of AWT020 in Advanced Cancer

Phase 1 Recruiting

Advanced Cancer

NCT05735496 2025-08-01

Clinical Trial of the TQB2102 Injection in Patients With Advanced Cancers

Phase 1 Active not recruiting

Advanced Cancer

NCT06963814 2025-07-17

Study of HC006 in Combination With a PD-1 Inhibitor in Patients With Advanced Solid Tumors

Phase 1 Recruiting

Advanced Cancer

NCT05276310 2025-06-27

A Study of IMC-002 in Patients With Advanced Cancer Failed to Standard Therapy

Phase 1 Recruiting

Advanced Cancer

NCT06707610 2025-03-12

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Antitumor Activity of ALK202 in Participants with Advanced Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Advanced Cancer

NCT03352531 2025-02-28

Study of the Safety, Pharmacokinetics, and Antitumor Activity of AK105 in Subjects With Advanced Solid Tumors

Phase 1 Completed

Advanced Cancer

NCT04270864 2024-10-18

PRIMO

Phase 1 Terminated

Advanced Cancer

NCT02193633 2024-09-26

TAX-TORC

Phase 1 Completed

Advanced Cancer

NCT02338622 2024-09-26

ComPAKT

Phase 1 Completed

Advanced Cancer

NCT02944864 2024-09-23

A Phase I Study of TQ-B3395 on Tolerance and Pharmacokinetics

Phase 1 Terminated

Advanced Cancer

NCT01394016 2024-09-19

A Phase 1 Study of LY2835219 In Participants With Advanced Cancer

Phase 1 Completed

225 enrolled 31 charts

Advanced Cancer

NCT04335253 2024-09-19

First-In-Human Study of EOS884448 in Participants with Advanced Cancers.

Phase 1 Completed

Advanced Cancer

NCT05128539 2024-03-26

A Study Explore JS001+JS002 in Patients With Advanced Cancer

Phase 1 Terminated

Advanced Cancer

NCT05894421 2024-03-12

TQB2223 Injection in Combination With Penpulimab in Patients With Advanced Cancers

Phase 1 Recruiting

Advanced Cancer

NCT01954316 2024-01-17

A Study of CFI-400945 Fumarate in Patients With Advanced Cancer

Phase 1 Completed

Advanced Cancer

NCT00610194 2023-10-18

Phase 1 Dose-escalation PK/PD Trial in Advanced Cancer Patients

Phase 1 Completed

Advanced Cancer

NCT04864418 2023-07-20

AST-021p Study in Advanced Solid Tumors

Phase 1 Unknown

Advanced Cancer

NCT00658671 2023-02-06

A Dose-Escalation Study of ENMD-2076 Administered Orally to Patients With Advanced Cancer

Phase 1 Completed

Advanced Cancer

NCT05262842 2022-09-21

JS001+IMP4297 in Patients With Advanced Cancer

Phase 1 Withdrawn

Advanced Cancer

NCT01113476 2022-09-02

Nab-paclitaxel, Gemcitabine, and Bevacizumab in Advanced Malignancies

Phase 1 Completed

Advanced Cancer

NCT03312842 2022-05-26

A Phase Ia/Ib Study of CS1001 in Subjects With Advanced Solid Tumors

Phase 1 Completed

Advanced Cancer

NCT03444753 2022-05-23

An Investigational Immunotherapy Study of BMS-986299 Alone and in Combination With Nivolumab and Ipilimumab in Participants With Solid Cancers That Have Spread or Cannot be Removed

Phase 1 Terminated

Advanced Cancer

NCT03851146 2022-05-03

LeY-CAR-T

Phase 1 Completed

Advanced Cancer

NCT03203876 2022-03-10

A Safety Study of Lirilumab in Combination With Nivolumab or in Combination With Nivolumab and Ipilimumab in Advanced and/or Metastatic Solid Tumors

Phase 1 Completed

Advanced Cancer

NCT05192512 2022-03-03

Clinical Trial of the TQB2928 Injection in Patients With Advanced Cancers

Phase 1 Unknown

Advanced Cancer

NCT03475251 2022-02-18

A Study of CS1003 in Subjects With Advanced Solid Tumors

Phase 1 Completed

Advanced Cancer

NCT01143779 2022-01-04

FLT-PET as an Imaging Biomarker With Temsirolimus, Topotecan, and Bortezomib

Phase 1 Completed

Advanced Cancer

NCT00687505 2021-12-13

Safety Study of FP-1039 To Treat Cancer

Phase 1 Completed

Advanced Cancer

NCT02407990 2021-11-17

Study of the Safety, Pharmacokinetics and Antitumor Activities of BGB-A317 in Participants With Advanced Tumors

Phase 1 Completed

451 enrolled 42 charts

Advanced Cancer

NCT03661632 2021-11-08

An Investigational Immunotherapy Study of BMS-986310 Administered Alone and in Combination With Nivolumab in Patients With Advanced Solid Tumors

Phase 1 Completed

Advanced Cancer

NCT03745807 2021-10-04

An Investigational Study of NKTR-214 Combined With Nivolumab in Japanese Participants With Advanced Solid Tumors

Phase 1 Completed

Advanced Cancer

NCT04071262 2021-09-21

A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Therapies in Japanese Participants With Advanced Cancer

Phase 1 Completed

Advanced Cancer

NCT05028218 2021-09-21

A Clinical Study of TQB3824 in Subjects With Advanced Cancer

Phase 1 Unknown

Advanced Cancer

NCT02797795 2021-03-03

A Phase 1, Open-Label, Dose-Escalation Study of NEV801, Administered to Patients With Advanced Cancers

Phase 1 Unknown

Other solid neoplasm

Advanced Cancer

NCT00085787 2020-10-14

A Study of ARRY-142886 in Patients With Advanced Cancer

Phase 1 Completed

Advanced Cancer

NCT00710736 2020-10-06

A Study of ARRY-334543 and Capecitabine in Patients With Advanced Cancer

Phase 1 Completed

Advanced Cancer

NCT00833326 2020-10-06

A Study of ARRY-334543 and Docetaxel in Patients With Advanced Cancer

Phase 1 Completed

Advanced Cancer

NCT00881569 2020-09-28

Extended Use Protocol for Participants With Cancer to Receive Continued Treatment With CS-7017

Phase 1 Completed

2 enrolled 9 charts

Advanced Cancer

NCT00543504 2020-06-30

Bevacizumab in Multiple Phase I Combinations

Phase 1 Completed

Advanced Cancer

NCT01596140 2020-06-04

Vemurafenib in Combination With Everolimus or Temsirolimus With Advanced Cancer

Phase 1 Completed

Other solid neoplasm

Advanced Cancer

NCT02992977 2020-06-02

Safety and Tolerability Study of AutoSynVax™ Vaccine in Subjects With Advanced Cancer

Phase 1 Terminated

Advanced Cancer

NCT01393990 2020-03-24

A Study of LY2228820 in Participants With Advanced Cancer

Phase 1 Completed

89 enrolled 30 charts

Advanced Cancer

NCT02383212 2020-01-27

Study of REGN2810 (Anti-PD-1) in Patients With Advanced Malignancies

Phase 1 Completed

Advanced Cancer

NCT01583777 2020-01-03

Phase I Mass Balance, PK and Safety Study of 14C-Labeled Belinostat in Patients With Advanced Cancer

Phase 1 Completed

Advanced Cancer